Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma. | J Gene Med;5(5): 407-16, 2003 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma.

Loudon, Peter T; McLean, Cornelia S; Martin, Gilly; Curry, Jayne; Leigh Shaw, M; Hoogstraten, Conny; Verdegaal, Els; Osanto, Susanne.

Affiliation

Loudon PT; Xenova Group plc, 310 Cambridge Science Park, UK. Peter_Loudon@xenova.co.uk

J Gene Med ; 5(5): 407-16, 2003 May.

Article in En | MEDLINE | ID: mdl-12731089

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Genetic Therapy / Mammary Neoplasms, Animal / Granulocyte-Macrophage Colony-Stimulating Factor / Herpesvirus 2, Human Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Gene Med Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2003 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Genetic Therapy / Mammary Neoplasms, Animal / Granulocyte-Macrophage Colony-Stimulating Factor / Herpesvirus 2, Human Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Gene Med Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2003 Document type: Article Affiliation country: Country of publication: